We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNSY
3926
Cerenome, Inc. Common Stock
CNSY
$25.5M
$25K ﹤0.01%
209
+20
+11% +$3.19K
DCOY
3927
Decoy Therapeutics
DCOY
$1.88M
$25K ﹤0.01%
11
-7
-39% -$24.8K
SNTI icon
3928
Senti Biosciences Holdings
SNTI
$12M
$25K ﹤0.01%
+1,770
New +$43.2K
VERO
3929
DELISTED
Venus Concept
VERO
$25K ﹤0.01%
465
+147
+46% +$6.61K
ZKIN icon
3930
ZK International Group
ZKIN
$60.8M
$25K ﹤0.01%
8,600
+5,841
+212% +$25.8K
RNTX
3931
Rein Therapeutics
RNTX
$67.4M
$25K ﹤0.01%
10,564
+1,029
+11% +$3.46K
NXXT
3932
NextNRG Inc
NXXT
$54.2M
$25K ﹤0.01%
4,395
-3,477
-44% -$34.8K
EQ icon
3933
Equillium
EQ
$127M
$24K ﹤0.01%
22,500
+5,300
+31% +$8.5K
IVVD icon
3934
Invivyd
IVVD
$202M
$24K ﹤0.01%
+15,800
New +$43.9K
NNBR icon
3935
NN Inc
NNBR
$298M
$24K ﹤0.01%
16,182
-81,618
-83% -$151K
XWEL icon
3936
XWELL
XWEL
$8.53M
$24K ﹤0.01%
3,305
+165
+5% +$1.83K
SUNE
3937
SUNation Energy
SUNE
$10.4M
– –
-1
Closed -$459K
OPGN
3938
DELISTED
OpGen, Inc
OPGN
$24K ﹤0.01%
867
+279
+47% +$10.3K
MF
3939
DELISTED
Missfresh Limited American Depositary Shares
MF
$24K ﹤0.01%
+13,574
New +$25.7K
NVIV
3940
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$24K ﹤0.01%
10,125
-17,600
-63% -$44.1K
CLWT icon
3941
Euro Tech Holdings
CLWT
$12.2M
$23K ﹤0.01%
16,400
-3,500
-18% -$5K
FRZA
3942
DELISTED
Forza X1, Inc. Common Stock
FRZA
$23K ﹤0.01%
+17,936
New +$29.9K
SCPX
3943
DELISTED
Scorpius Holdings, Inc.
SCPX
$23K ﹤0.01%
7
+2
+40% +$11K
QTT
3944
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$23K ﹤0.01%
33,580
+400
+1% +$216
SEGG
3945
Sports Entertainment Gaming Global Corp
SEGG
$7.89M
$22K ﹤0.01%
88
+32
+57% +$12.8K
NRSN icon
3946
NeuroSense Therapeutics
NRSN
$16.7M
$22K ﹤0.01%
18,433
-35,867
-66% -$57K
XNET
3947
Xunlei
XNET
$328M
$22K ﹤0.01%
11,943
-100,082
-89% -$157K
NIXX
3948
Nixxy Inc
NIXX
$19.8M
$22K ﹤0.01%
3,457
-1,456
-30% -$12.7K
TKAT
3949
DELISTED
Takung Art Co., Ltd.
TKAT
$22K ﹤0.01%
39,403
+11,103
+39% +$8.42K
INBS icon
3950
Intelligent Bio Solutions
INBS
$9.05M
$21K ﹤0.01%
44
-1
-2% -$959
156 157
158
159 160

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's Q4 2022 Portfolio in Review

As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
  • Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Jim Simons opened 626 new positions and closed 524 in Q4 2022.
  • Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.